Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size by Modality
2.3.2 Market Size by Application
2.3.3 Market Size by Product
2.3.4 Market Size by End-User
2.4 Market Share & Bps Analysis by Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material, Isotope & Component Suppliers
3.4.2 Molecular Imaging Equipment & Radiopharmaceutical Manufacturers
3.4.3 Distributors, Service Providers & Channel Partners
3.4.4 Hospitals, Diagnostic Centers & Research Institutes
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Disease Incidence & Diagnostic Imaging Trends (2025)
4.1.1 Global Cancer Incidence Requiring Molecular Imaging Procedures
4.1.2 Cardiovascular Disease Diagnostic Imaging Volume Trends
4.1.3 Neurological Disorder Imaging Utilization Rates
4.1.4 Regional Demand for Advanced Diagnostic Imaging
4.2 Molecular Imaging Procedure Volume Trends (2025)
4.2.1 PET Scan Procedure Volume by Region
4.2.2 SPECT Imaging Utilization Trends
4.2.3 PET-CT vs. PET-MRI Adoption Rates
4.2.4 Oncology Imaging Procedure Growth Trends
4.3 Radiopharmaceutical Usage Trends (2025)
4.3.1 Utilization of Fluorodeoxyglucose (FDG) Tracers
4.3.2 Growth in Targeted Radiotracer Applications
4.3.3 Diagnostic vs. Theranostic Radiopharmaceutical Demand
4.3.4 Regional Radiopharmaceutical Supply Trends
4.4 Healthcare Spending & Infrastructure Trends (2025)
4.4.1 Diagnostic Imaging Expenditure by Region
4.4.2 Investments in PET & SPECT Imaging Facilities
4.4.3 Expansion of Nuclear Medicine Centers
4.4.4 Government Funding for Advanced Imaging Technologies
4.5 Technology Innovation & Clinical Research Trends (2025)
4.5.1 AI Integration in Molecular Imaging Analysis
4.5.2 Clinical Trial Activity Involving Molecular Imaging
4.5.3 Advances in Hybrid Imaging Systems
4.5.4 Regulatory Approvals for Novel Imaging Agents and Technologies
5. Molecular Imaging Market Segmental Analysis & Forecast, By Modality, 2022 – 2035, Value (USD Billion)
5.1 Introduction
5.2 SPECT
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2035
5.3 PET-CT
5.4 PET
5.5 MRI
5.6 Others
6. Molecular Imaging Market Segmental Analysis & Forecast, By Application, 2022 – 2035, Value (USD Billion)
6.1 Introduction
6.2 Oncology
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022 – 2035
6.3 Neurology
6.4 Cardiology
6.5 Others
7. Molecular Imaging Market Segmental Analysis & Forecast, by Product, 2022 – 2035, Value (USD Billion)
7.1 Introduction
7.2 Systems/Equipment
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022 – 2035
7.3 Radiopharmaceuticals
7.4 Software
8. Molecular Imaging Market Segmental Analysis & Forecast, By End-User, 2022 – 2035, Value (USD Billion)
8.1 Introduction
8.2 Hospitals
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022 – 2035
8.3 Research Institutes
8.4 Diagnostic Centres
8.5 Others
9. Molecular Imaging Market Segmental Analysis & Forecast by Region, 2022 – 2035, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Molecular Imaging Market Size & Forecast, By Modality, 2022 – 2035
9.2.3 Molecular Imaging Market Size & Forecast, By Application, 2022 – 2035
9.2.4 Molecular Imaging Market Size & Forecast, by Product, 2022 – 2035
9.2.5 Molecular Imaging Market Size & Forecast, By End-User, 2022 – 2035
9.2.6 Molecular Imaging Market Size & Forecast, By Country, 2022 – 2035
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Molecular Imaging Market Size & Forecast, By Modality, 2022 – 2035
9.3.3 Molecular Imaging Market Size & Forecast, By Application, 2022 – 2035
9.3.4 Molecular Imaging Market Size & Forecast, by Product, 2022 – 2035
9.3.5 Molecular Imaging Market Size & Forecast, By End-User, 2022 – 2035
9.3.6 Molecular Imaging Market Size & Forecast, By Country, 2022 – 2035
9.3.6.1 Germany
9.3.6.2 United Kingdom
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Molecular Imaging Market Size & Forecast, By Modality, 2022 – 2035
9.4.3 Molecular Imaging Market Size & Forecast, By Application, 2022 – 2035
9.4.4 Molecular Imaging Market Size & Forecast, by Product, 2022 – 2035
9.4.5 Molecular Imaging Market Size & Forecast, By End-User, 2022 – 2035
9.4.6 Molecular Imaging Market Size & Forecast, By Country, 2022 – 2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Molecular Imaging Market Size & Forecast, By Modality, 2022 – 2035
9.5.3 Molecular Imaging Market Size & Forecast, By Application, 2022 – 2035
9.5.4 Molecular Imaging Market Size & Forecast, by Product, 2022 – 2035
9.5.5 Molecular Imaging Market Size & Forecast, By End-User, 2022 – 2035
9.5.6 Molecular Imaging Market Size & Forecast, By Country, 2022 – 2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Molecular Imaging Market Size & Forecast, By Modality, 2022 – 2035
9.6.3 Molecular Imaging Market Size & Forecast, By Application, 2022 – 2035
9.6.4 Molecular Imaging Market Size & Forecast, by Product, 2022 – 2035
9.6.5 Molecular Imaging Market Size & Forecast, By End-User, 2022 – 2035
9.6.6 Molecular Imaging Market Size & Forecast, By Country, 2022 – 2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 Egypt
9.6.6.5 South Africa
9.6.6.6 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2025
10.2.2 Year-Wise Strategies & Development, 2022 – 2025
10.2.3 Number of Strategies Adopted by Key Players, 2025
10.3 Market Share Analysis, 2025
10.4 Product/Service & Network Type Benchmarking
10.4.1 Product/Service Specifications & Features by Key Players
10.4.2 Product/Service Heatmap by Key Players
10.4.3 Network Type Heatmap by Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 GE Healthcare
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Siemens Healthineers
10.6.3 Philips Healthcare
10.6.4 Canon Medical Systems
10.6.5 Hitachi Medical
10.6.6 Toshiba Medical Systems
10.6.7 Bracco Diagnostics
10.6.8 Lantheus Holdings
10.6.9 Curium
10.6.10 Positron Corporation
10.6.11 Navidea Biopharmaceuticals
10.6.12 Molecular Templates
10.6.13 IBA
10.6.14 Sofie Biosciences
10.6.15 NovaBay Pharmaceuticals
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List of Tables
14.2 List of Figures
Frequently Asked Questions
The Molecular Imaging Market is expected to grow at a CAGR of 4.5% from 2026 to 2035.
The Molecular Imaging Market was valued at USD 9.25 Billion in 2025.
Rising global cancer and neurological disease incidence creating clinical imaging demand, novel radiopharmaceutical approvals expanding the addressable molecular imaging market into new disease categories, and theranostics programme growth creating combined diagnostic and therapeutic procurement that sustains above-average clinical imaging volume.
SPECT dominated the Molecular Imaging Market with 42% share in 2025, while PET-CT is the fastest growing modality.
North America dominated the Molecular Imaging Market in 2025, with the United States accounting for approximately 76% of North American revenues.